Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 2 » default

Pharmacogenomics and Personalized Medicine


Archive: Volume 2, 2009

Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine

Peter Avery, Shaymaa S Mousa, Shaker A Mousa

Pharmacogenomics and Personalized Medicine 2009, 2:79-91

Published Date: 13 September 2009

Pharmacogenomics in osteoporosis: Steps toward personalized medicine

Robert Greene, Shaymaa S Mousa, Mohamed Ardawi, et al

Pharmacogenomics and Personalized Medicine 2009, 2:69-78

Published Date: 10 September 2009

Genomics and proteomics: Applications in autoimmune diseases

Wolfgang Hueber, William H Robinson

Pharmacogenomics and Personalized Medicine 2009, 2:39-48

Published Date: 17 August 2009

Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid  dependence: A meta-analysis

Janet K Coller, Julia Beardsley, James Bignold, Yibai Li, Florence Merg, et al

Pharmacogenomics and Personalized Medicine 2009, 2:9-19

Published Date: 20 March 2009

Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction

Avery Schwartz, Shany Blum, Rabea Asleh, Mordechai Pollak, Shiri Kalet-Litman, Andrew P Levy

Pharmacogenomics and Personalized Medicine 2009, 2:1-8

Published Date: 27 February 2009